Multiple Trials Examined for RET-Targeted Therapies in MTC
September 27th 2021A 58-year-old man presented with a solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue. Twelve months after being treated with systemic therapy, symptoms occurred leading the oncologist to discover metastatic disease.
Usmani Considers Possible Treatments for a Patient With Relapsed/Refractory Multiple Myeloma
September 14th 2021Two year after being diagnosed with stage II multiple myeloma, a 78-year-old female patient was still receiving daratumumab plus lenalidomide maintenance and presented with mild fatigue during a routine follow-up.
Roundtable Discussion: Antonoff Discusses Treatment Goals in NSCLC
September 4th 2021An otherwise healthy 60-year-old woman, who has quit smoking for 8 years after 13 pack years, presented with a nonproductive cough. The patient was diagnosed with non–small cell lung cancer. Oncologists discuss the scenario during a Case-Based Roundtable event.
Roundtable Discussion: Oh and Participants Compare Second- and Third-Line Treatments for mCRPC
August 30th 2021In a 75-year-old patient with metastatic castration-resistant prostate cancer, a bone scan taken at 14-month follow-up showed evidence of 2 lesions in the right hip/pelvis, and abdominal/pelvic CT showed a 2.1-cm left pelvic lymphadenopathy.
Roundtable Discussion: Participants Discuss Treatment in Transplant-Ineligible DLBCL
August 20th 2021Grzegorz S. Nowakowski, MD and Stephen D. Smith lead other participants of a Case Based Roundtable event in a discussion around treatment for patients with transplant-ineligible diffuse large B-cell lymphoma.
Roundtable Discussion: Lee and Participants Debate Frontline Therapy in Intermediate-Risk RCC
August 17th 2021A 59-year-old Black woman received a diagnosis of clear cell renal cell carcinoma. Chung-Han Lee, Md, PhD and a group of other physicians discussed the patient's case during a Case-Based Roundtable event.